Biotech Values

[DewDiligence]

Results of the Pirfenidone Survey

There were 12 votes (one of the smallest vote totals for a survey on this board).

Q: What will be the outcome of the two phase-3 trials?

a) POSITIVE (both trials p<.05 on FVC with PFS showing at least a positive trend):
42%

b) NEGATIVE (nothing good from either trial):
8%

c) MIXED (only one trial positive or some other set of mixed outcomes):
50%

Thanks to all of the participants for participating.